FDA approval of Vanda’s Nereus marks a rare and meaningful regulatory milestone, introducing the first new pharmacologic ...
Hoth Therapeutics filed two provisional patent applications with the U.S. Patent and Trademark Office, expanding the ...
By the beginning of 2025, it was clear the GLP-1 drugs were going to remain a major part of the industry. Pfizer used its presentation at the 43 rd JP Morgan Healthcre Conference to detail plans to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback